BROOKFIELD ASSET MGMT-A (BAM)

CA1130041058 - Common Stock

39.18  -0.41 (-1.04%)

After market: 39.18 0 (0%)

Fundamental Rating

6

Overall BAM gets a fundamental rating of 6 out of 10. We evaluated BAM against 210 industry peers in the Capital Markets industry. BAM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BAM has a decent growth rate and is not valued too expensively.



8

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
In the past year BAM had a positive cash flow from operations.
Each year in the past 5 years BAM has been profitable.
Of the past 5 years BAM 4 years had a positive operating cash flow.

1.2 Ratios

BAM has a Return On Assets of 12.87%. This is amongst the best in the industry. BAM outperforms 94.23% of its industry peers.
BAM has a better Return On Equity (16.29%) than 78.85% of its industry peers.
BAM has a Return On Invested Capital of 17.78%. This is amongst the best in the industry. BAM outperforms 93.27% of its industry peers.
BAM had an Average Return On Invested Capital over the past 3 years of 14.85%. This is significantly above the industry average of 8.34%.
The 3 year average ROIC (14.85%) for BAM is below the current ROIC(17.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.87%
ROE 16.29%
ROIC 17.78%
ROA(3y)11.25%
ROA(5y)7.22%
ROE(3y)17.38%
ROE(5y)12.39%
ROIC(3y)14.85%
ROIC(5y)N/A

1.3 Margins

BAM has a Profit Margin of 45.27%. This is amongst the best in the industry. BAM outperforms 82.69% of its industry peers.
In the last couple of years the Profit Margin of BAM has grown nicely.
BAM's Operating Margin of 64.40% is amongst the best of the industry. BAM outperforms 96.15% of its industry peers.
In the last couple of years the Operating Margin of BAM has grown nicely.
Industry RankSector Rank
OM 64.4%
PM (TTM) 45.27%
GM N/A
OM growth 3Y0.56%
OM growth 5Y31.75%
PM growth 3Y34.81%
PM growth 5Y48.29%
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, BAM has more shares outstanding
Compared to 5 years ago, BAM has less shares outstanding
Compared to 1 year ago, BAM has a worse debt to assets ratio.

2.2 Solvency

BAM has an Altman-Z score of 4.38. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.38, BAM belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
BAM has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.14, BAM belongs to the top of the industry, outperforming 90.87% of the companies in the same industry.
BAM has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
BAM's Debt to Equity ratio of 0.02 is amongst the best of the industry. BAM outperforms 83.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.14
Altman-Z 4.38
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BAM has a Current Ratio of 2.36. This indicates that BAM is financially healthy and has no problem in meeting its short term obligations.
BAM's Current ratio of 2.36 is fine compared to the rest of the industry. BAM outperforms 73.56% of its industry peers.
BAM has a Quick Ratio of 2.36. This indicates that BAM is financially healthy and has no problem in meeting its short term obligations.
BAM's Quick ratio of 2.36 is fine compared to the rest of the industry. BAM outperforms 73.56% of its industry peers.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 2.36

4

3. Growth

3.1 Past

The earnings per share for BAM have decreased strongly by -41.70% in the last year.
BAM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.79% yearly.
BAM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.99%.
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -40.99% yearly.
EPS 1Y (TTM)-41.7%
EPS 3Y65.07%
EPS 5Y-9.79%
EPS growth Q2Q2.86%
Revenue 1Y (TTM)11.99%
Revenue growth 3Y23.55%
Revenue growth 5Y-40.99%
Revenue growth Q2Q1.16%

3.2 Future

The Earnings Per Share is expected to grow by 14.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.68% on average over the next years. This is quite good.
EPS Next Y12.11%
EPS Next 2Y14.28%
EPS Next 3Y14.6%
EPS Next 5YN/A
Revenue Next Year11.57%
Revenue Next 2Y14.42%
Revenue Next 3Y13.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

BAM is valuated quite expensively with a Price/Earnings ratio of 28.60.
Based on the Price/Earnings ratio, BAM is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 25.25. BAM is around the same levels.
Based on the Price/Forward Earnings ratio of 25.51, the valuation of BAM can be described as expensive.
71.63% of the companies in the same industry are cheaper than BAM, based on the Price/Forward Earnings ratio.
BAM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.67.
Industry RankSector Rank
PE 28.6
Fwd PE 25.51

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAM indicates a rather cheap valuation: BAM is cheaper than 91.83% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BAM is valued a bit cheaper than the industry average as 70.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.38
EV/EBITDA 5.28

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BAM does not grow enough to justify the current Price/Earnings ratio.
BAM has an outstanding profitability rating, which may justify a higher PE ratio.
BAM's earnings are expected to grow with 14.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.36
PEG (5Y)N/A
EPS Next 2Y14.28%
EPS Next 3Y14.6%

4

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 3.44%. Purely for dividend investing, there may be better candidates out there.
BAM's Dividend Yield is comparable with the industry average which is at 7.77.
BAM's Dividend Yield is a higher than the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

BAM has paid a dividend for at least 10 years, which is a reliable track record.
BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

DP0%
EPS Next 2Y14.28%
EPS Next 3Y14.6%

BROOKFIELD ASSET MGMT-A

NYSE:BAM (4/24/2024, 6:50:16 PM)

After market: 39.18 0 (0%)

39.18

-0.41 (-1.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap16.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.6
Fwd PE 25.51
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.87%
ROE 16.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 64.4%
PM (TTM) 45.27%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.36
Quick Ratio 2.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-41.7%
EPS 3Y65.07%
EPS 5Y
EPS growth Q2Q
EPS Next Y12.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.99%
Revenue growth 3Y23.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y